DarioHealth Corp. (DRIO)
Chart Events
Performance Outlook
| Previous Close | 15.79 |
| Open | 15.81 |
| Bid | 15.20 x 1000 |
| Ask | 15.55 x 800 |
| Day's Range | 15.33 - 15.81 |
| 52 Week Range | 7.10 - 31.85 |
| Volume | 93,552 |
| Avg. Volume | 268,839 |
| Market Cap | 255.011M |
| Beta (5Y Monthly) | 1.34 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -4.31 |
| Earnings Date | Aug 10, 2021 - Aug 16, 2021 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 27.86 |
- PR Newswire
DarioHealth Chosen to Provide Remote Patient Monitoring for Alabama Regional Medical Services
DarioHealth Corp. (Nasdaq: DRIO), a pioneer in the global digital therapeutics market, today announced it has been selected as a digital health provider by Alabama Regional Medical Services (ARMS), a Federally Qualified Health Center (FQHC) accredited by The Joint Commission and designated as a Primary Care Medical Home serving patients in Jefferson, Shelby, St. Clair, and Blount counties.
- Zacks Small Cap Research
DRIO: Dario’s Evolving Strategic Vision
By John Vandermosten, CFA NASDAQ:DRIO READ THE FULL DRIO RESEARCH REPORT Revenue Opportunities On July 12, 2021, DarioHealth Corp. (NASDAQ:DRIO) announced the closure of three new employer client contracts derived from wayForward relationship. Average revenue per user for these contracts is expected to be in the low single digit range; however, the agreements were unexpected and provide an
- PR Newswire
DarioHealth Chief Medical Officer Omar Manejwala, M.D., to Present on the Role of Digital Therapeutics in Post-Pandemic Healthcare at DTx Europe
DarioHealth Corp. (Nasdaq: DRIO), a leader in the global digital therapeutics (DTx) market, announced Chief Medical Officer Omar Manejwala, M.D. will present "Rebalancing: Digital Therapeutics in a Post-Pandemic Healthcare System" during the virtual conference DTx Europe on July 14th at 5:55 a.m. EST.
